# RISEDRONATE SODIUM
> **ANDA205066** · Abbreviated New Drug Application (Generic) · Sponsor: IMPAX LABS INC · Approved 2018-06-29
## Drug
- **FDA Application Number:** ANDA205066
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RISEDRONATE SODIUM
- **Generic name:** Risedronate Sodium
- **Active ingredients:** RISEDRONATE SODIUM
- **Dosage form:** TABLET, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** IMPAX LABS INC
- **First approval:** 2018-06-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205066)
---
*AI Analytics · CC0 1.0*